ex vivo bioavailability, seafood, marine organism sampling, antimicrobial resistance, novel antimicrobials, marine bacteria analysis, toxicity in vitro estimation,
Theme 2 - Evaluating
We are looking for consortia that might be interested to collaborate and include us for our research capacities.
We can offer water sampling and research expertise, relevant to the call sub theme 2.2 and concretely, on
1) Estimation of the transmission of pollutants and pathogens to and from the aquatic environment, biota
and humans as well as through the food chain (trophic transfer) and via water exposures; and/or
2)Understanding the factors that control the bioavailability and fate of emerging pollutants, pathogens
and antimicrobial resistant bacteria in organisms such as uptake, mode of action, biological end-points;
3) Identification of human key-target groups with risk of higher exposure.
4) Determination of the incremental health risk caused by environmental exposures to antibiotic resistant
5) Assessing the occurrence of CECs in seafood, developing strategies to remove/reduce contaminants
The Møreforsking group is the largest private, non-profit regional institute in Norway. The main objectives are to pursue research- and development activities and provide counselling for the benefit of industry, public administrations and other partners. We work in direct collaboration with numerous local, national and international SMEs. The Institute’s focus is interdisciplinary research on marine resources covering the full value chain from ocean to consumer. Important research areas include sustainable management of coastal eco systems, bioeconomy and harvesting of marine resources, impact on the climate, seafood processing and quality, aquatic animal welfare, integrated multitrophic aquaculture, exploitation of new marine resources, 100% exploitation of raw materials, chemical and biochemical analysis, health benefits of marine oils and proteins, and consumer behaviour and markets. The institution has various laboratory infrastructures, including a laboratory for analytical biochemistry and a facility for live marine organisms,and counts with optimized laboratory protocols for simulated human in vitro digestion, bioavailability in vitro and ex vivo, toxicological estimations and biomedical research, in collaboration with local hospitals.